Open an account

Orthometrix

OMRX · OTC

$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About OMRX

Orthometrix, Inc. engages in the marketing, sale, and servicing of musculoskeletal product lines used in research, diagnostic, and monitoring of bone and muscle disorders, sports medicine, rehabilitative medicine, physical therapy, fitness, and pain management. The company is headquartered in Naples Florida, Florida and currently employs 7 full-time employees. The firm offers five product lines. The firm markets, sells and services its products primarily in the United States and Canada. The company markets, sells and services its products and devices through two divisions: Healthcare Division and Sports & Fitness Division. The Sports & Fitness Division markets, sells and services the exercise systems, which include the Mini VibraFlex, Mini VibraFlex Plus, VibraFlex 550, among others. The Healthcare Division markets, sells and services include pQCT bone and muscle measurement systems for use in musculoskeletal research applications.

Employees
7
Headquarters
Naples Florida, Florida
Listed
Nov 3, 1998
Sector
Health Care
Industry
Health Care Equipment & Supplies

OMRX key statistics

Market cap
53
Price-earnings ratio
—
Dividend yield
—
Average volume
320
Volume
115
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$0.00
52 Week low
$0.00

Orthometrix (OMRX) at a glance

As of Sep 23, 2026, Orthometrix (OMRX) shares are priced at $0.00, giving the company a market cap of 53.

Volume so far is 115 shares, below the average of 320 shares a day.

Orthometrix met or beat analyst EPS estimates in 3 of the last 6 quarters. In Q1 FY98 it reported -$0.26 per share against an estimate of -$0.153.

OMRX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 6 quarters, by 15.1% on average.

  1. Q4 FY96: reported $0.03 per share against an estimate of $0.0714
  2. Q1 FY97: reported $0.07 per share against an estimate of $0.0612
  3. Q2 FY97: reported $0.09 per share against an estimate of $0.0816
  4. Q3 FY97: reported $0.08 per share against an estimate of $0.0663
  5. Q4 FY97: reported -$0.01 per share against an estimate of $0.0918
  6. Q1 FY98: reported -$0.26 per share against an estimate of -$0.153

Similar companies

Companies in the same industry as Orthometrix

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.